FDA Investigator Paulene M Wohlgemuth
Paulene M Wohlgemuth has conducted inspections on 54 sites in 1 countries as of 24 Nov 2003. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
24 Nov 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Paulene M Wohlgemuth:
Adam C Hipko,
Alvaro G Dominguez, Jr,
Anh M Lac,
Betsy C Galliher,
Brackens Harris,
Brandon C Heitmeier,
Carol A Declouette Wilburn,
Charles B Steinmiller,
Chris A Lane,
Christopher J Hurst,
Constance M Dobbins,
Dale L Graham,
Dan G Eisenbrey,
Daniel J Lahar,
Daniell Gill, Jr,
Danielle Lyke,
Darla J Christopher,
David C Hayward,
David J Leray,
Dawn P Hall,
Debra D Devlieger,
Denise Connelly,
Ed Gonzalez Vazquez,
Edward D Edmiston,
Elizabeth D Connell,
Emilio O Escobar,
Ernest Serna, III,
Florecia S Philogene,
Francisco J Mendoza,
Frans E Mercado,
Gery M Duparc,
Glasgow Glasgow,
Grant L Davis,
Haley L Coleman,
Hung V Le,
J Elkins,
Jd Young,
Jeremy R Read,
Jerry E Lott,
Jocelyn C Turner,
John Ahearn,
Johnson,
Juan D Lopez,
Kari M Johansen,
Karlton T Watson,
Kathleen Chmura Shaffer,
L Grant,
Leighton Kn Gai,
Lisa M Puttonen,
Mark C Flotte,
Martha S Baldwin,
Maximiano Perez,
Monique Rac Lester,
Patrick D Stone, MS,
Paul E Frazier,
Philip M Steele, PhD,
Rebecca Co Bryan,
Rene R Ramirez,
Rian L Pope,
Roosevelt Turner,
Sean M Cheney,
Selina M Mata,
Sharon E O Neal,
Staci G Mcallister,
Steven L Strom,
Tamera H Hunt,
Toby Vern H Hill,
Tricia S Martinez,
Trina K Vick,
Yvette S Montes
Paulene M Wohlgemuth's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | EIR | Pepsi Bottling Group - EIR, 2000-03-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more